Approval · Notice of Compliance 20128 · 2017
DATSCAN: Notice of Compliance 20128
Issued December 7, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20128
- Date
- December 7, 2017
- Company
- Ge Healthcare Canada IncMississauga, Ontario, Canada
- Product type
- Radiopharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DATSCAN | Not yet assigned | — |
Medicinal ingredients
- IOFLUPANE (123I) 74 MBQ per ML